A phase I study of LSTA1 in combination with HIPEC interoperative intraperitoneal lavage in peritoneal carcinomatosis
Latest Information Update: 21 Aug 2023
At a glance
- Drugs Cerepetide (Primary)
- Indications Peritoneal cancer
- Focus Adverse reactions
Most Recent Events
- 21 Aug 2023 New trial record
- 14 Aug 2023 According to a Lisata Therapeutics media release, the company plans to initiate this study in fourth quarter of 2023 and the first patient being treated shortly thereafter.